Line 29: | Line 29: | ||
} | } | ||
#HQ_page td{ | #HQ_page td{ | ||
− | padding | + | padding:0; |
− | + | ||
− | + | ||
− | + | ||
border:0; | border:0; | ||
vertical-align: top; | vertical-align: top; | ||
Line 202: | Line 199: | ||
} | } | ||
table tr td.right{ | table tr td.right{ | ||
− | width: | + | width: 729px; |
− | + | margin-left: 20px; | |
vertical-align: text-top; | vertical-align: text-top; | ||
} | } |
Revision as of 11:51, 10 October 2016
Safety
|
SYSU-MEDICINE is trying to reinforce the homing ability of hMSCs toward the inflamed tissue by constructing the plasmids with the chemokine receptors and locate them with fluorescence. In addition, we design a switch to kill themselves when they differentiate into cells of other types. We spared no effort to achieve the safety control. |
Safety Project Design
Parts Selection |
SYSU-MEDICINE is trying to reinforce the homing ability of hMSCs toward the inflamed tissue by constructing the plasmids with the chemokine receptors and locate them with fluorescence. In addition, we design a switch to kill themselves when they differentiate into cells of other types. We spared no effort to achieve the safety control. |